SSG
PODD icon

Summit Securities Group’s Insulet PODD Stock Holding History

Summit Securities Group’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12
Closed -$313K – 823
2021
Q1 		$313K Buy
+12
New +$3.21K 0.03% 430

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Summit Securities Group's PODD Position: Q1 2026 in Review

Summit Securities Group reduced its Insulet (PODD) stake by 88% in Q1 2026, selling an estimated $23.1K and leaving 12 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Summit Securities Group first reported a position in PODD in Q1 2023 and has held it in 6 quarters since. The position peaked at $43K in Q1 2023. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Summit Securities Group held 12 shares of Insulet worth $2.52K as of Q1 2026.
  • Summit Securities Group sold 92 Insulet shares in Q1 2026, an estimated $23.1K.
  • Insulet made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #917 holding.
  • Summit Securities Group first reported a position in Insulet in Q1 2023 and has held it in 6 quarters since.
  • Summit Securities Group's Insulet position peaked at $43K in Q1 2023.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.